Found 4 matching trials
Pharmacokinetic, Efficacy, and Safety Study of Recombinant Factor VIII Single Chain (rVIII-SingleChain) in Children With Severe Hemophilia A PHASE3 This is an international, multicenter, open-label study to assess the effic...
Show More Learn More & Join Trial
An Open-label Safety, Efficacy and Pharmacokinetic Study of a Recombinant FVIII Compared to Recombinant Human Antihemophilic FVIII in Patients With Severe Hemophilia A PHASE2 This is an open-label, non-randomized, efficacy, safety and pharmacokinetic...
Show More Learn More & Join Trial
An Open-label Safety and Efficacy Study of Recombinant FVIII in Patients With Severe Hemophilia A PHASE3 This multicenter, open-label, phase 3 extension study will investigate the ...
Show More Location
Study Site 8400213
Learn More & Join Trial
Recombinant Single-chain Factor VIII (rVIII-SingleChain) in Chinese Participants With Hemophilia A Previously Treated With FVIII Products PHASE3 For bridging the available global clinical data of rVIII-SingleChain, with ...
Show More Status
Active Not Recruiting
Location
The Second Hospital of Anhui Medical University
Learn More & Join Trial